Checkpoint inhibitor rechallenge is possible for select patientsJune 6, 2019Immuno-oncologyImmunotherapyLung Cancer
Low-dose CT lung cancer screening nets payoff in community setting tooJune 5, 2019Lung CancerLung Cancer
Antiangiogenics linked to fatal bleeds after RT in patients with “ultracentral” lung tumorsMay 18, 2019Lung Cancer
Do some EGFR mutation subtypes benefit from immune checkpoint blockade?May 17, 2019Lung CancerImmuno-oncology
Myc signaling, monocytes predict NSCLC response to second-line entinostat + pembroMay 2, 2019Lung CancerImmuno-oncology
SRA737 + anti–PD-L1 therapy and low-dose gemcitabine shows early promise for SCLCApril 30, 2019Lung CancerImmuno-oncology
MYSTIC trial: bTMB correlates with tTMB, predicts survival in mNSCLCApril 30, 2019Lung CancerImmuno-oncology
